2012-09-18 07:54:16 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Ovarian Disease - Pipeline Review, H2 2012', provides an overview of the Ovarian Disease therapeutic pipeline. This report provides information on the therapeutic development for Ovarian Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ovarian Disease. 'Ovarian Disease - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/463757_ovarian_disease_pipeline_review_h2_20 ..


Note*: Certain sections in the report may be removed or altered based on the availability

and relevance of data for the indicated disease.

Scope

* A snapshot of the global therapeutic scenario for Ovarian Disease.
* A review of the Ovarian Disease products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Ovarian Disease pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Ovarian Disease.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Ovarian Disease pipeline depth and focus of Ovarian Disease therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Ovarian Disease Therapeutic Products under Development, Key Players in Ovarian Disease Therapeutics, Ovarian Disease Pipeline Overview, Ovarian Disease Pipeline, Ovarian Disease Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Ovarian Disease Overview
Therapeutics Development
An Overview of Pipeline Products for Ovarian Disease
Ovarian Disease Therapeutics under Development by Companies
Ovarian Disease Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Ovarian Disease Therapeutics - Products under Development by Companies
Ovarian Disease Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Ovarian Disease Therapeutics Development
Respiratorius AB
Ovarian Disease - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
SPOC - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cyclophosphamide + Goserelin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Estradiol Patch - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Methylprednisolone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Leuprolide Acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Merional - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Triptorelin + Norethisterone Acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cabergoline - Drug Profile
Product Description
Mechanism of Action
R&D Progress
DHEA - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Ovarian Disease Therapeutics - Drug Profile Updates
Ovarian Disease Therapeutics - Dormant Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Ovarian Disease, H2 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463757&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.